3-Methylglutaconic aciduria type 2
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study provides substantial support for translation of an adeno-associated virus serotype 9-mediated TAZ gene replacement strategy using a Des promoter for human BTHS patients in the clinic.
|
30070157 |
2019 |
Abnormal palate morphology
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Abnormality of the skeletal system
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Myofibrillar myopathy with congenital cataract and skeletal anomalies without mutations in the desmin, alphaB-crystallin, myotilin, LMNA or SEPN1 genes.
|
17005401 |
2006 |
Acute flaccid paralysis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Desmin and HSP27, both indirectly regulate the contraction of muscle cells, were significantly downregulated as a result of EV71 infection, suggesting a link to acute flaccid paralysis.
|
21621020 |
2011 |
Adenoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Loss of IHH from Apc(HET) mice changed the composition of the adenoma stroma; cells that expressed α-smooth muscle actin or desmin were lost, along with expression of cyclooxygenase-2, and the number of vimentin-positive cells increased.
|
25307863 |
2015 |
Adenoviral infections
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Overexpression of mutant desmin by adenoviral infection in cultured cardiomyocytes led to increased mitochondrial fission, inhibition of mitochondrial respiration, and activation of cellular toxicity.
|
29987122 |
2018 |
Adult Desmoplastic Small Round Cell Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We present a 51 year old female patient with a pelvic desmoplastic small round cell tumor with an unusual immunohistochemical profile, including absence of significant cytokeratin expression, complete negativity for desmin and widespread loss of nuclear INI-1 expression (>90% of tumor cells).
|
25755805 |
2015 |
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The intermediate filament protein synemin is present in astrocyte progenitors and glioblastoma cells but not in mature astrocytes.
|
22337773 |
2012 |
Adult Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Myospryn and desmin are shown to be expressed in the brain and myospryn is shown to localize to the cytoplasm and nucleus of myoblast, neuroblastoma, and glioblastoma cell lines.
|
30658136 |
2019 |
Adult Leiomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The results confirmed IMFT positivity for smooth muscle actin, desmin and cytokeratin in 78-89% cases, resulting in potential confusion with sarcomatoid carcinoma or leiomyosarcoma.
|
15105807 |
2004 |
Adult Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In most cases, they can be distinguished from lymphoma (leucocyte common antigen, B and T markers) and embryonal rhabdomyosarcoma (muscle specific actin, desmin).
|
8183732 |
1993 |
Adult Oligodendroglioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Unexpected expression of intermediate filament protein genes in human oligodendroglioma cell lines.
|
7529297 |
1995 |
Adult rhabdomyoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical stains performed on the cell block showed the tumor cells were desmin positive and negative for S-100 and PAX-8, supporting the diagnosis of an adult rhabdomyoma.
|
29131558 |
2018 |
Adult Rhabdomyosarcoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Adult-type rhabdomyosarcoma (RMS) has been classically defined as a pleomorphic sarcoma with desmin expression occurring in adult patients.
|
19898221 |
2009 |
Adult Rhabdomyosarcoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
In contrast to RD cells that expressed preferentially myoid and not neurofilament proteins (NFPs) upon treatment with UDP-4, differentiated RD/TE-671 cells exhibited characteristic dendritic processes and expressed NFPs (NFP68, NFP160, and NFP200), parvalbumin (calcium-binding protein), and neuron-specific enolase, as well as a small amount of vimentin and desmin.
|
8780893 |
1996 |
Adult Rhabdomyosarcoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical positive staining with vimentin (80% of tumour cells), desmin (20%) and titin (30%) antibodies was suggestive of a rhabdomyosarcoma.
|
9543674 |
1998 |
Adult Rhabdomyosarcoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
A significant component of the tumor was composed of pleomorphic eosinophilic spindle cells in whorls and interlacing fascicles that showed a strong, sharp, and diffuse positivity for desmin, thus mimicking rhabdomyosarcoma.
|
22899016 |
2012 |
Adult Rhabdomyosarcoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Rhabdomyosarcoma showed muscle-specific actin positivity in 4 and desmin positivity in 3 cases.
|
11285617 |
2001 |
Adult Rhabdomyosarcoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
In addition, MAbs to the cytoplasmic protein desmin, myoglobin, muscle actin (alpha and gamma) and alpha-sarcomeric actin reacted with these cell lines, SCMC-RM2 and SCMC-RM2-1 being thus identified as rhabdomyosarcoma.
|
2323848 |
1990 |
Alexander Disease
|
0.080 |
Biomarker
|
disease |
BEFREE |
Moreover, dominant mutations in the GFAP gene, coding for glial fibrillary acidic protein (GFAP), a principal astrocytic intermediate filament protein, have been shown to lead to AD.
|
17043438 |
2006 |
Alexander Disease
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Alexander disease (AxD) is a usually fatal astrogliopathy primarily caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed in astrocytes.
|
22488673 |
2012 |
Alexander Disease
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Alexander disease (AxD) is a rare but fatal neurological disorder caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP).
|
16507904 |
2006 |
Alexander Disease
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
GFAP is the principal astrocyte intermediate filament protein and dominant mutations in the GFAP gene have been shown to lead to Alexander disease, a fatal neurodegenerative condition in humans.
|
15495269 |
2004 |
Alexander Disease
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
We have been studying the astrocytes of Alexander disease (AxD), which is caused by heterozygous mutations in the GFAP gene, which is the gene that encodes the major astrocyte intermediate filament protein.
|
28135564 |
2017 |
Alexander Disease
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Alexander disease (AxD) is a neurodegenerative disease caused by heterozygous mutations in the GFAP gene, which encodes the major intermediate filament protein of astrocytes.
|
28700643 |
2017 |